• Profile
Close

Evaluation of the small-aperture intracorneal inlay: Three-year results from the cohort of the US Food and Drug Administration clinical trial

Journal of Cataract & Refractive Surgery May 27, 2018

Vukich JA, et al. - Authors assessed the safety and effectiveness of the Kamra small-aperture intracorneal inlay. Intracorneal implantation of the inlay in the nondominant eye was seen in patients with emmetropic presbyopia. Findings suggested safety and effectiveness of the small-aperture corneal inlay, improving near vision both monocularly and binocularly with minimal effect on distance visual acuity. Over 3 years, 8.7% were removed from the full cohort. In the 6 × 6 pocket group, the removal rate was significantly less and further reduced with deeper implantation. Severe glare or halos were reported in less than 1.0% of the patients postoperatively.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay